メタボリックシンドローム

□記事を途中から表示しています
[最初から表示]

^ 岩波明『精神科医が狂気をつくる　臨床現現場からの緊急警告』、新潮社、2011年6月15日発行、158ページ
 ^ 滋賀医科大上島弘嗣教授『日米共同調査』
^ “カロリーとは”. 株式会社タニタ. 2023年7月22日閲覧。
^ a b Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
^ a b DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-194.
^ a b Kaplan NM. The deadly quartet: upper body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med 1989; 149: 1514-1520.
^ Lemieux I, Pascot A, et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small dense LDL) in men? Circulation 2000; 102: 179-184.
^ Ridker PM, Wilson PW, et al. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004; 109: 2818-2825.
^ Dandona P, Aljada A, et al. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005; 111: 1448-1454.
^ Iso H, Kobayashi M, et al. Intake of fish and n-3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-based (JPHC) Study Cohort 1. Circulation 2006; 113: 195-202.
^ Ouellet V, Marois J, et al. Dietary cod protein improves insulin sensitivity in insulin-resistant men and women. Diabetes Care 2007; 30: 2816-2821.
^ a b Riserus U, Arnlov J, et al. Long-term predictors of insuli resistance. Role of lifestyle and metabolic factors in middle-aged men. Diabetes Care 2007; 30: 2928-2933.
^ Oh SW, Yoon YS, et al. Association between cigarette smoking and metabolic syndrome: the Korea National Health and Nutrition Examination Survey. Diabetes Care 2005; 28: 2064?2066.
^ Gustat J, Srinivasan SR, et al. Relation of self-rated measures of physical activity to multiple risk factors of insulin resistance syndrome in young adults: the Bogalusa Heart Study. J Clin Epidemiol 2002; 55: 997-1006.
^ Ford ES, Giles WH, et al. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
^ Apridonidze T, Essah PA, et al. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004; 90: 1929-1935.
^ Ruderman NB, Schneider SH, et al. The “metabolically-obese,” normal-weight individual. Am J Clin Nutr 1981; 34: 1617-1621.
^ Nakamura T, Tokunaga K, et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Athyerosclerosis 1997; 107: 239-246.
^ Lamarche B, Tchernof A, et al. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 1998; 279: 1955-1961.
^ World Health Organization. Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO Consultation. Geneva, World Health Org, 1999.
^ Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabetes Med 1999; 16: 442-443.
^ Lemieux I, Pascot A, et al. Hypertriglyceridemic waist. A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000; 102: 179-184.
^ Expert Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
^ Einhorn D, Reaven GM, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003; 9: 237-252.
^ Ridker PM, Wilson PWF, et al. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004; 109: 2818-2825.
^ Grundy SM, Cleeman JI, et al. Diagnosis and management of the metabolic syndrome: a statement for health care professionals: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
^ Kahn R, Buse J, et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289-2304.
^ a b Grundy SM. Does the metabolic syndrome exist? Diabetes Care 2006; 29: 1689-1692.
^ Kahn R. The metabolic syndrome (emperor) wears no clothes. Diabetes Care 2006; 29: 1693-1696.
^ a b c Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr 2006; 83: 1237-1247.
^ Grundy SM. Does a diagnosis of metabolic syndrome have value in clinical practice. Am J Clin Nutr 2006; 83: 1248-1251.
^ Ferrannini E. Metabolic syndrome: a solution in search of a problem. J Clin Endocrinol Metab 2007; 92: 396-398.
^ Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007; 92: 399-404.
^ Kahn R. Metabolic syndrome. Is it a syndrome? Does it matter. Circulation 2007; 115: 1806-1811.
^ Beaser RS, Levy P. Metabolic syndrome. A work in progress, but a useful construct. Circulation 2007; 115: 1812-1818.
^ Sundstrom J, Vallhagen E, et al. Risk associated with the metabolic syndrome versus the sum of its individual components. Diabetes Care 2006; 29: 1673-1674.
^ Eckel RH, Kahn R, et al. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Circulation 2006; 113: 2943-2946.

次ページ

記事の検索

おまかせリスト

Size:70 KB
出典: フリー百科事典『ウィキペディア（Wikipedia）』
担当:undef